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identified, but those that acetylate either the 6- or
3-amino substituents are the most prevalent in amino-
glycoside-resistant clinical strains [4].
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1300 Morris Park Avenue of aminoglycoside-resistant S. enterica [5]. This nor-
Bronx, New York 10461 mally cryptically expressed gene was implicated in the
resistant phenotype as a result of a massive 60 Kbp
genomic deletion that placed the constitutive promoter
of the nmpC-encoded outer membrane porin directly up-Summary
stream of the sgcE, -R, and aac(6) genes, resulting in
the constitutive expression of the aac(6)-Iy gene (FigureThe Salmonella enterica chromosomally encoded
1A). The predicted 145 amino acid enzyme showed sig-AAC(6)-Iy has been shown to confer broad aminogly-
nificant primary sequence homology with other amino-coside resistance in strains in which the structural
glycoside 6-acetyltransferases and members of thegene is expressed. The three-dimensional structures
Gcn5-related N-acetyltransferase (GNAT) superfamily.reported place the enzyme in the large Gcn5-related
The aac(6)-Iy gene was expressed and the purified pro-N-acetyltransferase (GNAT) superfamily. The struc-
tein was shown to catalyze the regioselective 6-N-acet-ture of the CoA-ribostamycin ternary complex allows
ylation of a broad array of aminoglycosides, includingus to propose a chemical mechanism for the reaction,
ribostamycin (Figure 1B) [6]. The enzyme binds aminogly-and comparison with the Mycobacterium tuberculosis
coside substrates and acetyl-CoA randomly and synergis-AAC(2)-CoA-ribostamycin complex allows us to de-
tically, with the release of the product CoA being ratefine how regioselectivity of acetylation is acheived.
limiting [7].The AAC(6)-Iy dimer is most structurally similar to
the Saccharomyces cerevisiae Hpa2-encoded histone
acetyltransferase. We demonstrate that AAC(6)-Iy
Results and Discussioncatalyzes both acetyl-CoA-dependent self--N-acety-
lation and acetylation of eukaryotic histone proteins
and the human histone H3 N-terminal peptide. These Structure Determination
structural and catalytic similarities lead us to propose Diffraction data at three X-ray wavelengths of the Se-
that chromosomally encoded bacterial acetyltransfer- Met-substituted S. enterica AAC(6)-Iy were used to
ases, including those functionally identified as amino- solve the structure by multiwavelength anomalous dif-
glycoside acetyltransferases, are the evolutionary pro- fraction (Table 1). The tertiary structure of the S. enterica
genitors of the eukaryotic histone acetyltransferases. AAC(6)-Iy monomer (Figure 2A) is similar to those ob-
served previously for aminoglycoside acetyltransfer-
ases and other members of the GCN5-related N-acetyl-Introduction
transferase (GNAT) superfamily [8, 9]. The N-terminal
region is composed of a short  strand (1) and two Aminoglycosides were one of the first natural products
helices (1 and 2, all shown in green in Figure 2A). Theidentified as antibacterial agents and bind to the ac-
completely conserved secondary structural elements ofceptor site (A site) of the 30S ribosomal subunit, where
this fold are the three antiparallel strands (2–4, shownthey inhibit protein synthesis by inhibiting initiation and
in yellow), the long, central helix and adjacent strandcause code misreading [1]. Resistance to aminoglyco-
(3 and 5, shown in red) and the carboxy-terminal sides is of increasing clinical concern and may be due
to target modification, including rRNA methylation in helix (4, shown in blue). The pantetheine arm of coen-
aminoglycoside-producing organisms [1] or mutations zyme A binds between 4 and 5 in a manner similar
in the 16S rRNA or the S12 protein in M. tuberculosis to all other GNAT members [10]. The assembly of the
[2]. However, the vast majority of clinical resistance to catalytically active dimer generates a continuous sheet
aminoglycosides results from the expression of en- that includes 1–6 from one monomer and 6–1 of
zymes that covalently modify the drug [3]. These include the adjacent monomer (Figure 2B). However, 6 of one
enzymes that catalyze either ATP-dependent O-phos- monomer is domain swapped between 5 and 6 of
phorylation or O-adenylylation and those that catalyze the adjacent monomer. Although not added in the crys-
the acetyl-CoA-dependent N-acetylation of the drug. tallization solutions, clear electron density due to bound
The plasmid-encoded N-acetyltransferases can act on CoA was observed in both subunits.
essentially all clinically useful aminoglycosides and are Intimate contacts between adjacent dimers in the two
responsible for the majority of worldwide clinical resis- different native crystal forms (Table 1) involve the
tance to aminoglycosides in Gram-negative pathogenic N-terminal His6/thrombin cleavage extension of one di-
bacteria. A number of different regioisozymes have been mer with an adjacent dimer (Figure 2C). The electron
density observed in both native crystal forms allows for
the unambiguous identification and positioning of the*Correspondence: blanchar@aecom.yu.edu
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Figure 1. Schematic of the Genomic Environment and a Typical Acetyltransferase Reaction of AAC(6)-Iy
(A) The genomic environment of the aminoglycoside-sensitive S. enterica BM4361 and aminoglycoside-resistant S. enterica BM4362. A 60
kilobase pair chromosomal deletion results in the constitutive nmpC promoter (black circle) being placed 2.2 kilobases upstream of the
aac(6)-Iy-encoded aminoglycoside acetyltransferase (red arrow).
(B) Ribostamycin acetylation catalyzed by aminoglycoside 6-N-acetyltransferase.
peptide in the channel. In both crystal forms, these con- The S. enterica acetyltransferase studied here catalyzes
the regioselective 6-N-acetylation of a wide variety oftacts involve amino acids that are elements of the throm-
bin cleavage sequence (VPR↓GSH). The peptide is both 4,6- and 4,5-disubstituted deoxystreptamines (e.g.,
tobramycin, ribostamycin, etc.) [6]. The structure of thebound in a long surface channel at the dimer interface
and is adjacent to the sulfur atom of bound CoA. In CoA-ribostamycin complex clearly indicates that the
primed and central rings make extensive electrostaticNative 2 crystals, the arginine residue of the peptide
makes specific, electrostatic contacts with the carboxyl- and hydrogen bonding interactions with the enzyme,
while a single interaction is observed between the riboseate groups of Glu79 and Asp115, and the peptide is
bounded top and bottom by the aromatic rings of Trp22 ring and the imidazole side chain of His25 (Figure 3C).
As we observed in the peptide-bound complex, the aro-and Tyr66, respectively (Figure 2D). In Native 1 crystals,
the polarity of the peptide orientation is reversed (data matic rings of Trp22 and Tyr66 stack above and below
the bound aminoglycoside, allowing for little conforma-not shown).
The structure of the enzyme-CoA-ribostamycin com- tional mobility when the substrate is bound (Figure 3D).
The amino and hydroxyl groups of the primed and cen-plex was determined by cocrystallizing the enzyme with
ribostamycin (Table 1). The quality of the electron den- tral deoxystreptamine rings make direct contacts with
the carboxyl-containing side chains of Glu79, Asp115,sity omit map (Figure 3A) allowed for the unambiguous
positioning of ribostamycin in the previously described and Glu136 that contribute to the intensely negatively
charged active site/dimer interface (Figure 3E). There ischannel (Figure 3B) at the dimer interface and allowed
us to identify the binding interactions between the en- sufficient room within the channel to accommodate a
sugar ring at the 6 position, arguing that aminoglycosidezyme and this substrate. The 6-amine is positioned
3.4 A˚ away from the sulfur atom of bound CoA, a position substrates for the enzyme such as tobramycin and kana-
mycin would bind in a similar fashion. In addition, theconsistent with both the known regioselectivity and the
required chemistry for acetyltransfer from acetyl-CoA. loops connecting 1 and 2 and 3 and 4, which
Table 1. Crystallographic Data, Phasing and Refinement Statistics
Data Collection and Phasing
Data Set Native 1 Peak
X-Ray Source Home Source Native 2 Ribostamycin BNL X-9X Inflection Remote
Wavelength (A˚) CuK 0.97917 0.97932 0.97152
Resolution (A˚) 20–2.4 20–3.0 20–2.0 20–3.2
Space group P3121 P3221 C2 P3221
Unit cell (A˚) a  62.8 a  84.5 a  85.0 b  44.7 a  85.1
c  157.4 c  66.7 c  88.0   93.9 c  66.7
Completeness (%) 98.0 (95.5) 95.3 (87.0) 93.0 (67.6) 97.9 (94.2) 97.1 (91.4) 89.6 (72.1)
Redundancy 5.0 (4.0) 4.0 (3.0) 3.7 (2.8) 8.9 (5.6) 6.6 (3.7) 2.8 (2.0)
I/sigI () 22.8 (11.7) 19.8 (5.1) 20.8 (10.6) 17.5 (4.8) 13.9 (2.9) 15.6 (3.9)
Rsym (%) 4.6 (9.0) 4.6 (13.6) 3.7 (10.6) 5.9 (16.4) 6.6 (19.4) 5.3 (15.2)
Refinement Statistics
Data Set Native 1 Native 2 Ribostamycin
Rcryst (%) 18.2 (16.8) 22.5 (28.1) 16.7 (17.8)
Rfree (%) 24.5 (24.5) 26.7 (35.5) 21.0 (22.7)
No. atoms protein/water/other 2270/161/106 1200/–/53 2318/217/169
Average B (A˚2) protein/water/other 26.1/29.2/26.1 57.8/–/62.2 21.3/30.1/24.9
Rmsd bond length (A˚) 0.021 0.015 0.021
Rmsd bond angle () 2.017 1.950 1.975
Values in parentheses correspond to the data in the highest resolution shell of data.
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Figure 2. Overall Fold of AAC(6)-Iy
(A) The crystallographically determined structure of the S. enterica AAC(6)-Iy monomer. The coloring conforms to the amino-terminal residues
(1, 1, 2, green), the central  strands (2–4, yellow), the central  helix and  strand (3, 5, red), and the carboxy-terminal region (4,
6, blue). CoenzymeA and ribostamycin are colored by atom type. This coloring scheme is used throughout.
(B) The S. enterica AAC(6)-Iy dimer showing the position of bound CoA and ribostamycin (stick representation, colored by atom type). The
exchange of the 6 and 6 strands is noted.
(C) The interaction between two S. enterica AAC(6)-Iy dimers showing the N terminally extended peptide, colored by atom type, interacting
with an adjacent dimer.
(D) Closeup of the interaction between the crystallographically observable N terminally extended peptide and the active site channel. The
dimer is presented in surface representation with each monomer colored in silver or bronze.
contain Trp22 and Tyr66, respectively, are flexible, ribostamycin is hydrogen bonded to a water molecule
and the backbone carbonyl of D115 in the adjacent 5allowing variously substituted aminoglycosides to be
bound and acetylated. These observations account for (Figure 4A), and therefore does not directly interact with
a side chain group that could act as a general base.the broad substrate specificity of the enzyme for both
4,5- and 4,6-disubstituted deoxystreptamines used clin- However, this water molecule is, in turn, hydrogen
bonded to the carboxyl side chain of D115, where twoically.
unusually short hydrogen bonds (2.65 A˚) are observed
between (1) the D115 carboxylate and the water mole-Chemical Mechanism and Regioselectivity
cule and (2) the water molecule and the 6-amine, sug-The acetylation of aminoglycosides occurs after the ran-
gesting that deprotonation of the amine may occur viadom binding of both acetyl-CoA and 6-amine-con-
this intervening water molecule during the nucleophilictaining aminoglycosides to the enzyme and has been
attack on the thioester. There is no obvious candidateproposed to proceed via a direct nucleophilic attack by
for a general acid that could protonate the thiolate anionthe amine on the thioester [6]. The pantetheine arm of
after collapse of the tetrahedral intermediate. There isCoA interacts with main chain residues of4 that include
a tightly bound sulfate anion at the position where wethe structurally conserved  bulge, centered at residue
show a water molecule, and we suggest that thiolateE79, on 4. In the structures of acetyl-CoA complexes
protonation occurs using a water molecule accessibleof other GNAT superfamily members, the carbonyl oxy-
to bulk solvent. The very favorable energetics of the acetyl-gen of acetylCoA makes a single hydrogen bonding
transfer chemistry and the close proximity of the twointeraction with a backbone amide nitrogen, corre-
sponding to I81N in our structure [10]. The 6-amine of reactants apparently are sufficient to promote the chem-
Chemistry & Biology
568
Figure 3. The AAC(6)-Iy Ribostamycin Complex
(A) Ribostamycin is shown modeled into a Fo-Fc simulated annealing omit electron density map contoured at 3 .
(B) Ribostamycin bound at the active site of AAC(6)-Iy. Both CoA and ribostamycin are colored according to atom type, and each monomer
surface is colored in either silver or bronze.
(C) Scheme showing the interactions observed between AAC(6)-Iy and ribostamycin. Primed residues are contributed by the adjacent
monomer.
(D) Stereo diagram of residues in the AAC(6)-Iy active site that are 5 A˚ or less from either the CoA or ribostamycin. The coloring of the carbon
atoms of each monomer is similar to (B), as is the relative orientation.
(E) A molecular surface of the AAC(6)-Iy dimer-CoA-ribostamycin complex colored by its electrostatic potential (red, 10 Kt; blue, 	10 Kt)
as calculated in GRASP [28]. CoA and ribostamycin are represented in stick fashion and colored by atom type, and the peptide/aminoglycoside
binding channel is overwhelmingly electronegative.
ical reaction, without the requirement for directly hydro- AAC(6)-Iy and M. tuberculosis AAC(2) oriented to high-
light the similarities of the monomer fold and the confor-gen-bonded general acid or base groups.
The high-resolution structures of two aminoglycoside mation of bound CoA. The three rings of ribostamycin
assume the same ring puckers in both complexes, andacetyltransferase-CoA-ribostamycin complexes (M. tu-
berculosis AAC(2) [11] and the S. enterica AAC(6)-Iy) the deoxystreptamine and 2,6-dideoxy-2,6-diamino glu-
cose rings are nearly perpendicular to each other in bothpermit an examination of how two structurally similar
GNATs can bind the same substrates but regioselec- complexes. In the AAC(6) complex, the hydroxyl and
amino substituents of the deoxystreptamine and primedtively acetylate two amine functions of the same ring.
Prior to these studies, multiple conformations of amino- ring make interactions directly or via intervening water
molecules with residues on N-terminal structural ele-glycosides bound to Enterococcus faecium AAC(6)-Ii
and AAC(3) were determined using NMR spectroscopy ments, including 3, 4, and 2. In the AAC(2) complex,
2 covers these strands, and ribostamycin interacts with[12, 13]. Figure 4B shows one monomer of S. enterica
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Figure 4. Comparison of AAC(6)-Iy and AAC(2)-Ic
(A) Proposed chemical mechanism of S. enterica AAC(6)-Iy aminoglycoside N-acetyltransferase.
(B) Aligned views of a single active site of the AAC(6)-Iy-CoA-ribostamycin and the M. tuberculosis AAC(2)-CoA-ribostamycin complexes,
respectively. The monomers are aligned to maximize the overlap of the monomer and bound CoA molecules. Opposing monomers of the
dimer are colored in gray.
(C) Conformations of bound ribostamycin in the S. enterica AAC(6)-Iy-CoA-ribostamycin and the M. tuberculosis AAC(2)-CoA-ribostamycin
complexes, respectively. The central, deoxystreptamine ring was used to align the two molecules.
residues on C-terminal structural elements, including define the regioselectivity of the two reactions catalyzed
by these structurally similar enzymes.5, 9, and 4, and the C-terminal carboxylate of W181
of the same monomer. In the AAC(6) complex, the
2-amino group of ribostamycin makes an interaction Dimer Interface and Protein Acetylation
The monomer fold of AAC(6)-Iy is similar to many ofwith the 5″-hydroxyl group of the ribose ring (Figure
4C), and this interaction is stabilized by an interaction the previously determined aminoglycoside N-acetyl-
transferases and other GNAT superfamily members.between the 2″-hydroxyl group and the imidazole ring
of H25, located on the short loop connecting 1 and However, the unique subunit interactions that generate
the active dimer create a structure that is most structur-2. This intramolecular interaction orients the 6-amino
group toward acetylCoA. In contrast, a minor rotation ally similar to the tetrameric, 163 amino acid S. cerevis-
iae Hpa2 histone acetyltransferase [14], with a root-about the pseudoglycosidic linkage of ribostamycin in
the AAC(2) complex moves the 6-amino group toward mean-square deviation for 134 of the 145 amino acids of
AAC(6)-Iy of 1.42 A˚, despite sharing only 19.6% primarythe ribose ring. The ribose ring is rotated almost 180
relative to its position in the AAC(6) complex, and the sequence identity. Like AAC(6)-Iy, the Hpa2 dimer is
generated by similar subunit interactions, including the2″-hydroxyl now makes an intramolecular hydrogen bond
with the 6-amino group, thus orienting the 2-amino group 6 strand exchange noted above. A superposition of
the AAC(6)-Iy and Hpa2 dimers is shown in Figure 5A.toward acetylCoA. These remarkably subtle differences
Figure 5. Comparison of AAC(6)-Iy and HPA2
(A) Overlay of AAC(6)-Iy dimer and the yeast Hpa2 histone acetyltransferase. AAC(6)-Iy is colored as in Figure 2A, while the two monomers
of Hpa2 are colored in black (top) and gray (bottom).
(B) Space-filling models of AAC(6)-Iy and Hpa2. Bound CoA is colored in orange, and ribostamycin is colored in blue. The loop region
connecting 3 and 4 is highlighted in yellow in both models.
(C and D) MALDI-TOF mass spectrum of AAC(6)-Iy-His6 before (C) and after (D) overnight incubation with acetyl-CoA.
(E) Top, Coomassie-stained SDS-PAGE of the time course of acetylation of calf thymus histone III-S by AAC(6)-Iy. Bottom, autoradiogram
of gel shown above.
(F) Time course of acetylation of human histone H3 peptide (100 
M) by AAC(6)-Iy (0.1 mg/ml) and acetyl-CoA (200 
M). MALDI-TOF mass
spectrometry of the reaction mixtures was used to qualitatively (peak height of each species/total peak height of all species) define the
acetylation state of the peptide.
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The major difference occurs at the dimer interface, spe- the initiator methionine. The second acetylation, which
represents 15% of the total peptide, was unambigu-cifically in the loop connecting 3 and 4. A structure-
based sequence alignment reveals a three-residue dele- ously assigned as occurring on the second histidine in
the His6 sequence (H5). The -N-terminal acetylation oftion in Hpa2, resulting in a shorter connecting loop that
truncates the channel at the dimer interface leading the N terminally His6-tagged construct (Figure 5E) likely
occurs intermolecularly and is not likely to be physiologi-away from CoA (shown in yellow in Figure 5B).
The structural similarity of the bacterial AAC(6)-Iy with cally significant.
The S. enterica N-acetyltransferase is also an efficientthe yeast Hpa2 histone acetyltransferase, the similar
position of binding of aminoglycoside substrates and histone acetyltransferase. As shown in Figure 5E, incu-
bation of calf thymus histone III-S preparations withpeptides, and the negatively charged surface of the di-
mer interface led us to explore the possibility that AAC(6)-Iy-His6 and [acetyl-14C]-acetyl-CoA led to very
rapid histone acetylation, which can be compared toAAC(6)-Iy-His6 (C-terminal His6 affinity tag) could acet-
ylate cationic proteins or peptides. Incubation of the the very slow relative rate of AAC(6)-Iy autoacetylation.
In order to determine whether histone acetylation byenzyme with [acetyl-14C]acetyl-CoA resulted in the time-
dependent acetylation of the enzyme (data not shown). the bacterial N-acetyltransferase is stoichiometric and
regioselective, we determined the ability of AAC(6)-Iy toIn order to confirm this autoacetylation, we performed
mass spectrometry (MS) on AAC(6)-Iy-His6 before and acetylate the 21 amino acid human histone H3 N-terminal
peptide (ARTK4QTARK9STGGK14A-PRK18QLC). This pep-16 hr after the addition of acetyl-CoA. The molecular
mass of the carboxy-terminal His6-tagged enzyme was tide is rapidly monoacetylated (60% in 15 min) and more
slowly diacetylated, and after long incubation times, tri-,calculated to be 17,184.3, and the major peak we ob-
served exhibited a mass of 17,183 prior to incubation tetra-, and penta-acetylated forms of the peptide are
observed (Figure 5F). Base treatment prior to MS argueswith acetyl-CoA, indicative of the nonacetylated full-
length protein (Figure 5C). An additional peak was ob- that acetylation is occurring exclusively on amino
groups. This kinetic discrimination is most likely the re-served at a molecular mass of 17,947, a mass shift of 764
Da, corresponding to the AAC(6)-Iy-His6-CoA complex sult of regioselective acetylation, although we have no
information presently on the order in which the 4 -amino(predicted mass	 CoA 17,951). This is a noncovalent
but extremely tightly bound complex that remains par- groups of lysine or the -N terminus are acetylated.
Two other bacterial GNAT superfamily members, the E.tially intact in the mass spectrometer, supporting our
kinetic data concerning the rate-limiting nature of CoA faecium AAC(6)-Ii [9] and tabtoxin resistance protein
[15], have been shown to be capable of acetylating his-release [6]. Overnight incubation of the enzyme with
acetyl-CoA resulted in the appearance of a major mass- tones, but no analysis of either the stoichiometry or
regioselectivity of the acetylation was reported.shifted peak at 17,225, corresponding to the mono-acet-
ylated enzyme (expected: monoacetylated; 17,226 Da, An unanswered question of the present study remains
the identification of the physiological function of thisFigure 5D) and a similar shift in the enzyme-CoA com-
plex. While it is likely that acetylation occurs on the chromosomally encoded GNAT. The genomic environ-
ment of the gene, directly behind a long operon con-native -amino-N-terminus of the C terminally His6-
tagged construct based on data presented below, nei- taining both sugar transporter homologs and putative
sugar metabolizing enzymes [5], may suggest a functionther the locus nor the physiological significance of the
acetylation is known. in sugar metabolism. However, the enzyme is incapable
of O-acetylation, suggesting that it could only function inIn order to most easily identify the position of acetyla-
tion, we used the N terminally extended AAC(6)-Iy, aminosugar metabolism. While documented to catalyze
aminoglycoside 6-N-acetylation [6], it is also unlikelywhose structure we determined and examined the acet-
ylation reaction with [acetyl-14C]acetyl-CoA. This also that this represents a true physiological role. Our dem-
onstration that the enzyme can efficiently N-acetylatebecame acetylated, as evidenced by SDS-PAGE fol-
lowed by autoradiography (data not shown). Autoacety- proteins suggests a more reasonable physiological role,
although the protein or peptide substrate or substrateslation using unlabeled acetyl-CoA followed by thrombin
cleavage allowed us to determine the mass of the protein remain unknown.
and N-terminal peptide. A single peak corresponding
to the predicted mass of the cleaved, nonacetylated
Significanceenzyme was observed after thrombin cleavage either
in the absence or presence of acetyl-CoA (predicted,
The enzymological demonstration that AAC(6)-Iy binds16,643.8; observed, 16,642), suggesting that acetylation
aminoglycosides, proteins, and peptides and can bothoccurs on the N-terminal peptide. Incubation with ace-
-N-acetylate its amino terminus and regioselectivelytyl-CoA followed by thrombin cleavage yielded two pep-
acetylate aminoglycosides and a mammalian histonetide peaks corresponding to the predicted mass of the
peptide is remarkable. The structure that we presentdes-methionine acetylated peptide (predicted, 1810;
here of the S. enterica AAC(6)-Iy has revealed a long,observed, 1811) and a second peak corresponding to a
highly anionic channel generated at the dimer inter-des-methionine, di-acetylated peptide (predicted, 1852,
face and leading into the active site, where bothobserved, 1854). Using tandem mass spectrometry, we
aminoglycoside antibiotics and peptides are bound.identified the N-terminal glycine residue as the site of
Many of the same active site residues interact withthe first, stoichiometric acetylation. This requires that
both aminoglycoside and peptide. The structure ofthe enzyme catalyze its own -N acetylation after post-
translational enzymatic deformylation and removal of the acetyltransferase dimer is highly similar to the
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program O [24]. The program AMORE [25] was used to obtain theS. cerevisiae Hpa2 histone acetyltransferase, includ-
molecular replacement solution for the cross-crystal averaging anding the 6 exchange observed at the dimer interface
to determine the initial phases for the ribostamycin complex. Allin both enzymes but not in other bacterial aminogly-
structures were refined in the program CNS [26]. A subset (5%) of
coside N-acetyltransferases. Taken together, these the data was excluded from all steps of refinement and used only
data argue that bacterial acetyltransferases, including for the calculation of the Rfree [27]. The P3121 (Native 1) crystal form
contains a molecular dimer in the asymmetric unit (ASU): monomerthose identified as aminoglycoside acetyltransfer-
A (residues 1–145 plus 8 residues from the His6 tag) and monomerases, are the evolutionary progenitors of the well-stud-
B (residues 2–145 minus residues 22–31). The P3221 (Native 2) crystalied eukaryotic histone acetyltransferases.
form contains a monomer per ASU: monomer A (residues 1–145 plusThe extension of the structural and catalytic correla-
7 residues from the His6 tag). The ribostamycin complex contains ations between pro- and eukaryotic GNAT superfamily molecular dimer per ASU: monomer A (residues 1–145 plus 2 resi-
members, demonstrated here, to physiological functions dues from the His6 tag) and subunit B (residues 1–145). In all struc-
tures, there is one CoA and one sulfate ion bound per monomer.of regulation is tempting. In bacteria, there are only three
Ribostamycin is bound to both monomers in the ribostamycin com-enzymes proposed to catalyze protein acetylation.
plex. Root-mean-square deviations between various monomericThese are the RimJ, RimI, and RimL -N-acetyltrans-
structures ranged from 0.34–0.66 A˚2.ferases [16] that act on three ribosomal proteins, S5,
S18, and L12, all located near the acceptor site in Protein and Peptide Acetylation
the bacterial ribosome. The acetylation state of L12, Incubation of S. enterica AAC(6)-Iy with [14C-acetyl]-acetylCoA
whose N terminally acetylated product is termed L7, (Amersham) was performed overnight. Samples were heat dena-
tured (100C) in 0.1% SDS containing 1 mM -mercaptoethanol inis known to be correlated with growth phase, being
loading buffer containing dye for 3 min. PAGE was run on 10%–15%lowest during logarithmic growth and highest in sta-
gradient PhastGels using the PhastSystem (Pharmacia). Calf thymustionary phase [17]. A different protein acetylation mod-
histone preparation III-S (3 mg/ml, Sigma) was incubated with an
ification has been reported for Salmonella enterica equivalent concentration of S. enterica AAC(6)-Iy and [14C-acetyl]-
acetyl-CoA synthetase, where acetylation of the active acetylCoA for times from 0–90 min, followed by rapid heat denatur-
site Lys609 has been shown to inactivate the enzyme ation as described above. After SDS-PAGE as above, gels were
stained with Coomassie blue and destained, air dried, covered with[18]. Although the enzyme that catalyzes acetylation
plastic, and exposed for 24 hr in a ImagePlate cassette. Radioactivityof this residue is not known, protein acetylation by
was detected using a Storm 28 Phosphoimager system (Amersham-N-acetyltransferases in bacteria, both at the N termini
Pharmacia Biotech.) and quantitated using the ImageQuant 5.2
and at internal lysine residues, may serve important software provided by the manufacturer. Human histone H3 peptide
regulatory roles similar to those documented in eu- containing a C-terminal cysteine residue (100 
M,Upstate Biotech-
karyotes. nology) was incubated in 25 mM NH4HCO3 and 200 
M acetyl-
CoA. The reaction was initiated by the addition of AAC(6)-Iy (final
concentration 40 
g/ml), and at the indicated time intervals reac-Experimental Procedures
tions were quick frozen and lyophilized. The samples were taken
up in 0.1% TFA and mixed 1:1 with a saturated solution of-cyano-4-Protein Expression and Structure Determination
hydroxycinnamic acid in 50% aqueous acetonitrile containing 0.1%The S. enterica AAC(6)-Iy was expressed in Escherichia coli from
TFA. Matrix-assisted laser desorption ionization time-of-flightthe pET23 vector with a directly attached C-terminal His6 tag or, for
(MALDI-TOF) mass spectrometry was performed using an Appliedstructural studies, from the pET28a vector. Therefore, all crystals
Biosystems Voyager-DE mass spectrometer.contain an N-terminal His6 affinity tag and thrombin cleavage se-
quence. Three crystal forms of AAC(6)-Iy were obtained by vapor
Acknowledgmentsdiffusion under oil. P3121 crystals grew from 4 
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